References
- Rolinson GN. The significance of protein binding of antibiotics in antibacterial chemotherapy. J Antimicrob Chemother 1980; 6: 311–317.
- Wise R. Protein binding of 13-lactams: the effects on activity and pharmacology particularly tissue penetration I. J Antimicrob Chemother 1983; 12: 1–18.
- Wise R. Protein binding of 13-lactams: the effects on activity and pharmacology particularly tissue penetration II. J Antimicrob Chemother 1983; 12: 105–118.
- Wise R. The clinical relevance of protein binding and tis-sue concentrations in antimicrobial therapy. Clin Pharmacokin 1986; 11: 470–482.
- Craig WA, Welling PG. Protein binding and antimicro-bials: clinical pharmacokinetics and therapeutic implications. Clin Pharmacokin 1987; 9: 252–268.
- Drusano GL. Role of pharmacokinetics in outcome of infections. Antimicrob Agents Chemother 1988; 32: 289–297.
- Scaglione F, Demartini G, Dugnani S, Fraschini F. A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. Chemotherapy 1990; 34: 1056–1060.
- Rains CP, Bryson HM, Peters DH. Ceftazidime: an update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1995; 49 (4): 577–617).
- Patel IH, Chen S, Parsonnet M, et al. Pharmacokinetics of ceftriaxone in humans. Antimicrob Agents Chemother 1981; 20: 634–641.
- Scaglione F, Dugnani S, Demartini G, Arcidiacono MM, Cocuzza CE, Fraschini F. Bactericidal kinetics of an in vitro infection model of once-daily ceftriaxone plus amikacin against Gram-positive and Gram-negative bacteria. Chemotherapy 1995; 41: 239–246.
- National Committee for Clinical Laboratory Standards. Approved standard M7-A. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1990.
- Chan CY, French GL. Rapid high performance liquid chromatography assay of cephalosporins in biological fluids. J Antimicrob Chemother 1986; 18: 537–545.
- Merrikin DJ, Briant J, Rolinson GN. Effect of protein binding on antibiotic activity in vivo. J Antimicrob Chemother 1983; 11: 233–238.
- Bakker-Woundenberg IAIM, Van Den Berg JC, Vree TB, Baars AM, Michel MF. Relevance of serum protein bind-ing of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats. Antimicrob Agents Chemother 1985; 28: 654–659.
- Gerding DNL, Van Etta LL, Peterson LR. Role of serum protein binding and multiple antibiotic doses in the extravascular distribution of ceftizoxime and cefotaxime. Antimicrob Agents Chemother 1982; 22: 844–847.
- Van Etta LL, Kravitz GR, Russ TE, Fasching CE, Gerding DN, Peterson LR. Effect of method of administration on extravascular penetration of four antibiotics. Antimicrob Agents Chemother 1982; 21: 873–880.
- Peterson LR, Van Etta LL, Fasching CE, Gerding DN. Effect of protein binding on simulated intravascular and extravascular kinetics of cefotaxime in an in vitro model. Antimicrob Agents Chemother 1984; 25: 58–61.
- Tawara S, Matsumoto S, Kamimura T, Coto S. Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics. Antimicrob Agents Chemother 1992; 36: 17–24.
- Wiedemann B, Atkinson BA. Susceptibility to antibi-otics: species incidence and trends. In: Antibiotics in Laboratory Medicine, V. Lorian, ed. Baltimore, MD: Williams & Wilkins 1991; 962-1062.